BDTX-189, a novel tyrosine kinase inhibitor, inhibits cell activity via ERK and AKT pathways in the EGFR C797S triple mutant cells
-
Published:2024-05
Issue:
Volume:395
Page:111033
-
ISSN:0009-2797
-
Container-title:Chemico-Biological Interactions
-
language:en
-
Short-container-title:Chemico-Biological Interactions
Author:
Wang Rui,
Cui Wenrui,
Li Lanxin,
Wei Xiangkai,
Chu Chunhong,
Zhang Guoliang,
Liu Chenxue,
Xu Huixia,
Liu Chenyang,
Wang Ke,
Li Yanming,
An LeiORCID
Reference24 articles.
1. Lung cancer 2020: epidemiology, etiology, and prevention;Bade;Clin. Chest Med.,2020
2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin. Proc.,2008
3. The biology and management of non-small cell lung cancer;Herbst;Nature,2018
4. Toward personalized treatment approaches for non-small-cell lung cancer;Wang;Nat. Med.,2021
5. First-line immunotherapy for non-small-cell lung cancer;Reck;J. Clin. Oncol.,2022